Growth Metrics

GeneDx Holdings (WGS) Cash from Operations (2020 - 2026)

GeneDx Holdings has reported Cash from Operations over the past 7 years, most recently at 32408000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 418.29% to 32408000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 9311000.0 through Mar 2026, down 389.79% year-over-year, with the annual reading at 33279000.0 for FY2025, 216.78% up from the prior year.
  • Cash from Operations was 32408000.0 for Q1 2026 at GeneDx Holdings, down from 3090000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 15767000.0 in Q3 2025 and troughed at 88362000.0 in Q3 2022.
  • The 5-year median for Cash from Operations is 29858000.0 (2023), against an average of 30995705.88.
  • Year-over-year, Cash from Operations skyrocketed 458.75% in 2025 and then tumbled 418.29% in 2026.
  • A 5-year view of Cash from Operations shows it stood at 64654000.0 in 2022, then skyrocketed by 53.82% to 29858000.0 in 2023, then soared by 89.34% to 3183000.0 in 2024, then increased by 2.92% to 3090000.0 in 2025, then tumbled by 948.8% to 32408000.0 in 2026.
  • Per Business Quant, the three most recent readings for WGS's Cash from Operations are 32408000.0 (Q1 2026), 3090000.0 (Q4 2025), and 15767000.0 (Q3 2025).